PSOLVE+ is an online learning community for Canadian physicians with an interest in psoriasis and other dermatological conditions.

PSOLVE+ has been created to sustain a connection amongst Canadian physicians who treat psoriasis and other dermatological conditions, to exchange clinical findings and professional perspectives, promoting the highest level of care in Canada.

Members of PSOLVE+ will receive a weekly email digest with curated articles from sources identified by the PSOLVE+ faculty as well as periodic learning opportunities including online discussions, podcasts, webinars and polls.

LegitiMed will be managing this virtual community residing on Sosido (sosido.com).

If you are a Canadian physician interested in participating in PSOLVE+, you are invited to sign up here or contact paul.abbass@legitimed.com.

Thank you to Novartis Canada for their financial support of this initiative.

The PSOLVE+ community is designed for the scientific exchange of information between Healthcare Professionals and is made possible with financial support from Novartis Canada. Novartis does not itself monitor the discussions. However a third-party service provider does review the discussions only for the purpose of identifying any potential AE discussion. This review is required since as a drug manufacturer, Novartis has a regulatory obligation to report any AE that (directly or indirectly) comes to their attention. The third-party will only report the potential AE discussion and will include contact information. Should your post be reported to patient safety, you will be contacted by the third-party service provider to determine if you would like Novartis patient safety to contact you for more details.